| |
|
|
|
Pacific Biosciences  
|
|
3.87 0.14 (0.04%) |
08-03 13:22 |
|
Open: |
3.76 |
Pre close: |
3.73 |
Target:
|
4.95 
|
|
High: |
3.96 |
Low: |
3.76 |
Resistance:
|
4.24
4.95
|
|
Volume: |
424,841 |
Market Cap: |
596M |
Support:
|
3.69
3.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.81
|
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
3.90  |
Signal(12,26,9): |
0.05 |
|
MA(100): |
3.45 |
Stochastic Oscillator |
%K(14,3):
|
34.58 |
|
MA(250): |
4.37 |
%D(3): |
33.42 |
|
Average Volume(K) |
3-Month: |
118300
|
52-Week |
High:
|
5.94 |
|
10-Days: |
84652 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
53.10 |
Change(%): |
-28.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.343 |
Return on Equity (ttm) |
-67.7 |
Shares Out. (M) |
154.05 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-24.7 |
Shares Float (M) |
150.23 |
|
EPS Est. Next Year |
-0.640 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.33 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-5.0 |
% Held by Institutions |
87.94 |
|
Forward EPS |
-0.550 |
Gross Profit (p.s.) |
0.224 |
Shares Short (K) |
17850 |
|
Book Value (p.s.) |
0.390 |
EBITDA (p.s.) |
-0.493 |
P/E |
-11.38 |
|
Sales Per Share |
0.585 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.01 |
|
Profit Margin |
-58.35 |
Operating Cash Flow
(M) |
22.36 |
P/S |
6.68 |
|
Operating Margin |
-92.18 |
Levered Free Cash Flow
(M) |
76.13 |
P/CF |
26.90 |
|
|
|
|
|
|
